Home/nCage Therapeutics/Christopher Kaplan

CK

Christopher Kaplan

Chief Business Officer & Co-Founder

nCage Therapeutics

Therapeutic Areas

Infectious Disease Oncology

nCage Therapeutics Pipeline

Drug	Indication	Phase
Synthetic VLP Vaccines	Respiratory Diseases	Pre-clinical
Antibody Drug Conjugates (ADCs)	Oncology	Pre-clinical

Leadership Team at nCage Therapeutics

John V. Bason, Ph.D.

Chief Operating Officer & Co-Founder

Jonathan Heddle, Ph.D., D.Sc.

Chief Scientific Officer

View full nCage Therapeutics profile